论文部分内容阅读
目的探讨他汀类药物及中药血脂康对高血脂导致的动脉硬化干预的作用。方法选择103例血脂异常的高血压、冠心病、糖尿病患者随机分为治疗组和对照组;治疗组50例,应用辛伐他汀(30mg/d)及血脂康,每晚顿服1次。对照组53例应用辛伐他汀20mg/d,每晚顿服1次。共随访半年定期检测血脂。结果治疗组血脂降低78.3%对照组降低53.1%。两组之间差异有统计学意义(P<0.01)。结论应用他汀类药物能降低冠心病患者血脂的指标对心脑血管疾病的复发有很好的预防作用,从而降低冠心病患者的死亡和心脑血管事件的发生。
Objective To investigate the effect of statins and traditional Chinese medicine Xuezhikang on arteriosclerosis induced by hyperlipidemia. Methods 103 cases of dyslipidemia, coronary heart disease and diabetes mellitus were randomly divided into treatment group and control group. 50 cases in the treatment group were treated with Simvastatin (30mg / d) and Xuezhikang once a day. 53 cases of the control group simvastatin 20mg / d, Dayton night service 1 time. A total of six months follow-up of blood lipids. Results The treatment group decreased blood fat by 78.3% and the control group decreased by 53.1%. The difference between the two groups was statistically significant (P <0.01). Conclusion The use of statins can reduce the blood lipid in patients with coronary heart disease indicators of cardiovascular and cerebrovascular disease recurrence has a good preventive effect, thereby reducing the death of patients with coronary heart disease and cardiovascular and cerebrovascular events.